The Only Complete Online Marketing Firm
Sunday, October 18, 2015
Subgroup Analyses Show Consistent Benefits of Rivaroxaban (CME/CE)
(MedPage Today) -- Atrial fibrillation patients on new oral anticoagulants fare as well as warfarin-treated patients
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment